15 February 2020 by Malik Bisserier

Inhaled AAV1.SIN3a gene therapy restores BMPR2 expression and attenuates pulmonary arterial hypertension

About the author

profile picture of Malik Bisserier

Malik Bisserier


Icahn School of medicine at Mount Sinai

United States

Key Contributors

Malik Bisserier, Firas Elmastour, Shihong Zhang, Peter Dorfmüller, Marc Humbert, Yassine Sassi, Thomas Weber, Roger J Hajjar, Lahouaria Hadri Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, NY (M.B., SZ., Y.S., T.W., L.H) Translational Medicine Group, Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston,Massachusetts (F.E.) Hospital Antoine-Béclère, Clamart, France (P.D., M.H.); INSERM U999, Centre Chirurgical Marie-Lannelongue, Le Plessis-Robinson, France (P.D., M.H.) Phospholamban Foundation, Amsterdam, Netherlands (R.H)

Comments (0)

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI